Citation Impact
Citing Papers
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
2012 Standout
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Hepatitis C Virus Infection
2001 Standout
Virological assessment of hospitalized patients with COVID-2019
2020 StandoutNature
Human Genetics Shape the Gut Microbiome
2014 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
2006
Patterns of Bacterial Translocation in Experimental Biliary Obstruction
2006
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis
2003
Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction
2001
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
2006
T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C†
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Interferon-based therapy of hepatitis C
2007
Adaptive Immunity to the Hepatitis C Virus
2010
Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
2000
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
2013
Treating hepatitis C
2005 StandoutNobel
Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus
2004 Standout
Sarcoidosis in Patients With Chronic Hepatitis C Virus Infection
2005
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
2002
Ribavirin - current status of a broad spectrum antiviral agent
2001
Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection
2011
Current therapy for chronic hepatitis C
2000
A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
1999
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
2003 Standout
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Protective effect of 5-hydroxymethylfurfural derived from processed Fructus Corni on human hepatocyte LO2 injured by hydrogen peroxide and its mechanism
2010
Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization
2008
Independent risk factors and natural history of renal dysfunction in liver transplant recipients
2003
Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile
1999
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Sarcoidosis
2007 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade
2009
Gut Microbiota in Health and Disease
2010 Standout
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.
2003
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Biochemical and structural analysis of the NS5B RNA‐dependent RNA polymerase of the hepatitis C virus
2000
Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons
2002
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Metagenomics of the Human Body
2010
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells
2006 StandoutNobel
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
The Frequency of CD127 + Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection
2013 StandoutNobel
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain
2008
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Jin Ding being referenced
Obstructive Jaundice Impairs Reticuloendothelial Function and Promotes Bacterial Translocation in the Rat
1994
Protection against concanavalin A–induced hepatocyte apoptosis by molsidomine is time-dependent
2003
Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection
2005
Inhibition of amiloride-sensitive sodium-channel activity in distal lung epithelial cells by nitric oxide
1998
Ribavirin Inhibits Viral-Induced Macrophage Production of TNF, IL-1, the Procoagulant fgl2 Prothrombinase and Preserves Th1 Cytokine Production But Inhibits Th2 Cytokine Response
1998